
Loading, please wait...

Loading, please wait...

Fortis Healthcare recently released its Fortis Healthcare Q3 results, showing a 22% year-on-year decline in consolidated profit. Although the profit after tax (PAT) reached Rs 197 crore, this figure dropped from Rs 254 crore in the year-ago period. Consequently, the financial landscape reflects both significant operational hurdles and strong underlying revenue growth across its hospital network.
The reported profit includes a net exceptional loss of Rs 45.9 crore. Primarily, this loss stems from a one-time impact related to new labour codes. Moreover, the company balanced this against a reversal of impairment in an associate firm of Rs 9.4 crore. Meanwhile, revenue performed exceptionally well, increasing to Rs 2,265 crore compared to Rs 1,928 crore in the prior fiscal year. Therefore, the core business remains robust despite the temporary bottom-line pressure caused by regulatory adjustments.
Fortis Healthcare MD and CEO, Ashutosh Raghuvanshi, highlighted healthy growth in key specialties during the quarter. Specifically, renal sciences and orthopedics grew by 27% and 20%, respectively, over the previous period. Furthermore, the company is actively expanding its footprint in Bengaluru through recent acquisitions. This move strengthens its presence from 900 beds to a potential capacity of over 1,500 beds. Additionally, management is evaluating further inorganic opportunities within existing clusters to sustain clinical momentum.
Q1: What caused the decline in Fortis Healthcare\'s Q3 net profit?
The profit decline was primarily due to an exceptional loss of Rs 45.9 crore, which was linked to the one-time impact of new labour codes.
Q2: How did the revenue perform during the December 2025 quarter?
Revenue increased significantly to Rs 2,265 crore, representing a healthy rise from Rs 1,928 crore in the same quarter of the previous year.
Q3: Which medical specialties saw the most growth in this period?
Renal sciences and orthopedics were the top-performing specialties, growing by 27% and 20% respectively, indicating high demand for these clinical services.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Fortis Healthcare reported a 22% dip in Q3 profit to Rs 197 crore, impacted by one-time labour code costs, despite a strong 17.5% rise in consolidated reven...
6 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today